S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Dems push Biden climate, health priorities toward Senate OK
Dems' climate, energy, tax bill clears initial Senate hurdle
Transit woes mount for Boston's beleaguered subway riders
Shift in war's front seen as grain leaves Ukraine; plant hit
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Dems push Biden climate, health priorities toward Senate OK
Dems' climate, energy, tax bill clears initial Senate hurdle
Transit woes mount for Boston's beleaguered subway riders
Shift in war's front seen as grain leaves Ukraine; plant hit
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Dems push Biden climate, health priorities toward Senate OK
Dems' climate, energy, tax bill clears initial Senate hurdle
Transit woes mount for Boston's beleaguered subway riders
Shift in war's front seen as grain leaves Ukraine; plant hit
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Dems push Biden climate, health priorities toward Senate OK
Dems' climate, energy, tax bill clears initial Senate hurdle
Transit woes mount for Boston's beleaguered subway riders
Shift in war's front seen as grain leaves Ukraine; plant hit
NASDAQ:SELB

Selecta Biosciences (SELB) News Headlines

$2.36
+0.48 (+25.53%)
(As of 08/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.89
$2.54
50-Day Range
$0.77
$2.36
52-Week Range
$0.65
$4.70
Volume
6.54 million shs
Average Volume
1.65 million shs
Market Capitalization
$358.27 million
P/E Ratio
236.00
Dividend Yield
N/A
Price Target
$5.33
Get Selecta Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SELB and its competitors with MarketBeat's FREE daily newsletter.

SELB Media Mentions By Week

SELB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SELB
News Sentiment

0.90

0.34

Average
Medical
News Sentiment

SELB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SELB Articles
This Week

7

1

SELB Articles
Average Week



SourceHeadline
marketbeat.com logoSelecta Biosciences (NASDAQ:SELB) Announces Earnings Results
marketbeat.com - August 7 at 12:49 PM
seekingalpha.com logoSelecta Biosciences, Inc's (SELB) CEO Carsten Brunn on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 6 at 5:30 PM
finance.yahoo.com logoWhat Kind Of Investors Own Most Of Selecta Biosciences, Inc. (NASDAQ:SELB)?
finance.yahoo.com - August 6 at 12:29 PM
seekingalpha.com logoSelecta stock rises 13% on Q2 beat while revenue doubles
seekingalpha.com - August 4 at 1:15 PM
finance.yahoo.com logoSelecta Biosciences, Inc. (SELB) Q2 Earnings and Revenues Surpass Estimates
finance.yahoo.com - August 4 at 1:15 PM
finance.yahoo.com logoSelecta Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - August 4 at 8:15 AM
finance.yahoo.com logoSelecta Biosciences, Inc. (SELB) Upgraded to Strong Buy: Here's What You Should Know
finance.yahoo.com - July 28 at 5:07 PM
finance.yahoo.com logoSelecta Biosciences to Host Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Business Update
finance.yahoo.com - July 28 at 12:07 PM
MarketBeat logoAnalysts Set Selecta Biosciences, Inc. (NASDAQ:SELB) Price Target at $4.88
americanbankingnews.com - July 18 at 2:36 AM
finance.yahoo.com logoStrong week for Selecta Biosciences (NASDAQ:SELB) shareholders doesn't alleviate pain of five-year loss
finance.yahoo.com - July 14 at 11:41 AM
finance.yahoo.com logoVertex (VRTX) to Buy ViaCyte to Speed Up VX-880 Program
finance.yahoo.com - July 12 at 9:38 AM
finance.yahoo.com logoSelecta Biosciences to Participate at the Guggenheim I&I Spotlight Series – Treg-based Therapies Conference
finance.yahoo.com - July 6 at 2:40 PM
finance.yahoo.com logoSurface Oncology Appoints Carsten Brunn to Board of Directors
finance.yahoo.com - June 29 at 10:34 AM
markets.businessinsider.com logoExpert Ratings for Selecta Biosciences
markets.businessinsider.com - June 21 at 11:51 AM
finance.yahoo.com logoBioMarin (BMRN) Stock Jumps 5.4%: Will It Continue to Soar?
finance.yahoo.com - June 20 at 6:12 PM
finance.yahoo.com logoSome Analysts Just Cut Their Selecta Biosciences, Inc. (NASDAQ:SELB) Estimates
finance.yahoo.com - June 14 at 9:59 AM
finance.yahoo.com logoSelecta Biosciences Announces Partnership Advancements and Clinical Trial Updates
finance.yahoo.com - June 13 at 7:49 AM
finance.yahoo.com logoWhy Wall Street Doubts This Biotech Penny Stock Will Be Delisted
finance.yahoo.com - June 10 at 4:10 PM
finance.yahoo.com logoSVB Leerink Sees Over 600% Upside For This Penny Biotech Stock
finance.yahoo.com - June 6 at 6:33 PM
finance.yahoo.com logo7 Cheap Biotech Stocks to Buy Now
finance.yahoo.com - May 27 at 1:21 AM
finance.yahoo.com logoSelecta Biosciences to Participate at the H.C. Wainwright Global Investment Conference
finance.yahoo.com - May 17 at 8:14 AM
finance.yahoo.com logoCould The Market Be Wrong About Selecta Biosciences, Inc. (NASDAQ:SELB) Given Its Attractive Financial Prospects?
finance.yahoo.com - May 10 at 7:20 PM
markets.businessinsider.com logoNeedham Maintains Buy Rating for Selecta Biosciences: Here's What You Need To Know
markets.businessinsider.com - May 6 at 1:19 PM
seekingalpha.com logoSelecta Biosciences (SELB) CEO Carsten Brunn On Q1 2022 Results - Earnings Call Transcript
seekingalpha.com - May 6 at 1:36 AM
in.investing.com logoSelecta Biosciences Tops Q1 EPS by 34c
in.investing.com - May 5 at 9:50 AM
finance.yahoo.com logoSelecta Biosciences Announces Six Presentations at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
finance.yahoo.com - May 2 at 8:42 PM
finance.yahoo.com logoSelecta Biosciences to Host Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Business Update
finance.yahoo.com - April 28 at 10:13 AM
seekingalpha.com logoSelecta Biosciences to raise $38.7M in stock and warrants offering
seekingalpha.com - April 7 at 9:01 AM
finance.yahoo.com logoSelecta Biosciences Announces $38.7 Million Underwritten Offering
finance.yahoo.com - April 6 at 11:00 PM
finance.yahoo.com logoSelecta Biosciences to Participate at the 21st Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 4 at 10:32 AM
finance.yahoo.com logoSelecta Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
finance.yahoo.com - March 10 at 10:10 AM
seekingalpha.com logoSelecta Biosciences Q4 2021 Earnings Preview
seekingalpha.com - March 9 at 2:07 PM
benzinga.com logoEarnings Preview: Selecta Biosciences
benzinga.com - March 9 at 2:07 PM
finance.yahoo.com logoSelecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2021 Financial Results and Provide Business Update
finance.yahoo.com - March 3 at 12:08 PM
nasdaq.com logoShareholders in Selecta Biosciences (NASDAQ:SELB) are in the red if they invested five years ago
nasdaq.com - February 10 at 6:41 PM
finance.yahoo.com logoSelecta Biosciences to Participate at the SVB Leerink 11th Annual Global Healthcare Conference
finance.yahoo.com - February 9 at 12:55 PM
finance.yahoo.com logoSelecta taps Ginkgo for deal worth up to $1.1B
finance.yahoo.com - January 11 at 12:42 PM
finance.yahoo.com logoSelecta Biosciences and Ginkgo Bioworks Announce New Collaboration to Develop Next-Generation Gene Therapy Capsids
finance.yahoo.com - January 10 at 8:51 AM
finance.yahoo.com logoSelecta Biosciences to Participate at the 2022 H.C. Wainwright BioConnect Conference
finance.yahoo.com - January 5 at 9:11 AM
finance.yahoo.com logoSelecta Biosciences to Participate at the LifeSci Partners 11th Annual Corporate Access Event
finance.yahoo.com - December 29 at 12:42 PM
benzinga.com logoThinking about buying stock in Galera Therapeutics, Terminix Global, Aeglea Bio Therapeutics, Alzamend Neuro, or Selecta Biosciences?
benzinga.com - December 16 at 8:05 AM
nasdaq.com logoCarrie Cox Is The Independent Chairman of Selecta Biosciences, Inc. (NASDAQ:SELB) And They Just Picked Up 26% More Shares
nasdaq.com - December 12 at 12:28 PM
finance.yahoo.com logoTrade Alert: The Independent Chairman Of Selecta Biosciences, Inc. (NASDAQ:SELB), Carrie Cox, Has Just Spent US$51k Buying 26% More Shares
finance.yahoo.com - December 12 at 12:28 PM
finance.yahoo.com logoThe Petri Dish: Selecta hit with clinical hold, Biogen loses patent appeal
finance.yahoo.com - December 2 at 9:04 AM
markets.businessinsider.com logoSelecta's Gene Therapy Trial For Genetic Metabolic Disorder Put On FDA Hold
markets.businessinsider.com - November 26 at 8:59 AM
finance.yahoo.com logoSelecta Biosciences Provides Update on Phase 1/2 Clinical Trial of SEL-302 for the Treatment of Methylmalonic Acidemia
finance.yahoo.com - November 24 at 7:10 PM
finance.yahoo.com logoSelecta Biosciences to Participate in Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 11 at 9:26 AM
benzinga.com logoSelecta Biosciences's Return On Capital Employed Insights
benzinga.com - November 10 at 6:07 PM
finance.yahoo.com logoSelecta Biosciences, Inc. (SELB) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 9 at 3:13 PM
finance.yahoo.com logoSelecta Biosciences Reports Third Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - November 9 at 10:13 AM
finance.yahoo.com logoSelecta Biosciences Announces Top Line Data from the Phase I SEL-399 AAV Empty Capsid Study, Highlighting Potential Benefits of ImmTOR™ in Gene Therapy
finance.yahoo.com - November 8 at 8:50 AM
Get Selecta Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SELB and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:SELB) was last updated on 8/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.